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Impaired CD4+ T cell responses, resulting in dysregulated T-helper 1 (Th1) effector and memory responses, are a common result of
HIV-1 infection. These defects are often preceded by decreased expression and function of the α/β T cell receptor (TCR)–CD3 complex
and of co-stimulatory molecules including CD28, resulting in altered T cell proliferation, cytokine secretion and cell survival. We have
previously shown that HIV Tg rats have defective development of T cell effector function and generation of specific effector/memory T cell
subsets. Here we identify abnormalities in activated HIV-1 Tg rat CD4+ T cells that include decreased pY505 dephosphorylation of Lck
(required for Lck activation), decreased CD28 function, reduced expression of the anti-apoptotic molecule Bcl-xL, decreased secretion of the
mitogenic lympokine interleukin-2 (IL-2) and increased activation induced apoptosis. These events likely lead to defects in antigen-specific
signaling and may help explain the disruption of Th1 responses and the generation of specific effector/memory subsets in transgenic CD4+
T cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: HIV-1; Transgenic; Lck; CD28; MemoryIntroduction
Chronic HIV infection is distinguished by the gradual loss of
naive and memory phenotype CD4+ T cells. Direct killing was
initially thought to be the only mechanism by which HIV-1
leads to acquired immunodeficiency syndrome (AIDS). Quali-
tatively, however, early HIV infection affects the immune
system even before CD4+ T cell depletion occurs. T cells from
early asymptomatic infected persons with normal numbers of
circulating CD4+ T helper cells have an imbalanced ratio of
naive to memory phenotype CD4+ T cells and decreased T
helper activity (Miedema et al., 1988; Shearer et al., 1984, 1986;
Terpstra et al., 1989). It has been recently shown that during⁎ Corresponding author. Fax: +1 410 706 4694.
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doi:10.1016/j.virol.2006.05.026acute HIV and SIV infections there is a rapid and selective loss
of memory phenotype CD4+ T cells at mucosal sites and in
peripheral blood, with only a modest decrease in peripheral
CD4+ T cell numbers (Brenchley et al., 2004; Mattapallil et al.,
2005; Veazey et al., 1998), which may account for some (but not
all) of the dysregulation in immune responses during early
HIV-1 infection. The mechanism underlying this destruction of
existent Th1 memory/effector cells in acute HIV-1 infection is
not clear.
Activation of naive T cells is one of the earliest events in
the generation of effector and memory cells. Optimal acti-
vation of naive T cells requires at least two signaling events
(Bluestone, 1995; Bretscher and Cohn, 1970). The first is
mediated by T cell receptor (TCR) engagement with antigen
and MHC molecules on antigen presenting cells (APCs) and
initiates activation of Lck and other intracellular signaling
components. The second, termed co-stimulation, is most
Fig. 1. Tg rat CD4 T cells express reduced surface CD28. Expression of CD28
(as a function of mean channel fluorescence) from activated CD4 T cells from
12–18 month old Tg (n = 3) and non-Tg rats (n = 3) was analyzed by flow
cytometry. Times after stimulation at which analyses were performed are
indicated. Error bars indicate standard deviations. * indicates a significant
difference.
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on the naive T cell with B7-1 or B7-2 on the APC. CD28 co-
stimulation enhances cell cycle entry by causing further
changes in the phosphorylation status of Lck and activation of
a restricted set of intracellular signaling components. This in
turn stimulates expression of interleukin-2(IL-2) and anti-
apoptotic molecules (most prominently Bcl-xL), and facili-
tates the acquisition of effector and memory responses as well
as the induction of CD8+ T cell effector responses (Boise et
al., 1995; Michel and Acuto, 2002; Sharpe and Freeman,
2002). A lack of CD28 engagement on naive TCR-stimulated
T cells can result in clonal anergy (Harding et al., 1992;
Schwartz, 1990) and/or T cell apoptosis (Kerstan and Hunig,
2004).
The differentiation of naive T cells into memory T cells
is a crucial step in the evolution of an immune response and
subsequent memory formation. Memory formation depends
upon clonal expansion of naive T cells following an initial
encounter with antigen (primary response), the acquisition
of effector function (secretion of cytokines), a contraction
or “death phase” during which effector cell numbers are
reduced and finally memory development. As a conse-
quence of clonal expansion during the primary response,
the frequency of antigen-specific precursors significantly
increase; conditions that affect the primary immune
response may thus affect the overall generation of specific
CD4+ T cell memory (Ahmed and Gray, 1996; Kaech et al.,
2002). CD4+ T lymphocytes play a central role in the
immune containment of HIV. They contribute to HIV
clearance by providing help for B cell responses and by
maintaining effective CTL populations (Sun et al., 2005).
CD4+ T lymphocytes from HIV-1-infected individuals are
qualitatively dysfunctional and are skewed to an early
central memory phenotype (Yue et al., 2004), show a poor
ability to provide help and also manifest a dysregulation in
cytokine production such as reduced production of IL-2 and
or IFN-γ, all of which may be associated with poor clinical
outcome (Boaz et al., 2002; Sieg et al., 2001; Sun et al.,
2005).
We previously described an HIV-1 transgenic rat that
contains a gag/pol-deleted provirus (Reid et al., 2001, 2004),
expresses viral RNA and proteins in lymphocytes and
monocytes and develops Th1 immune response defects.
The spleens from these Tg rats manifest extensive depletion
of lymphocytes within the T cell region and B cell fo-
llicular hyperplasia. CD4+ and CD8+ T cells have defects
in IFN-γ production, a skewed early central memory phe-
notype and an increase in activation-induced T cell
apoptosis. Here we show defects in CD4+ T cells from
these rats, including decreased Lck(pY505) dephosphory-
lation, CD28 function, expression of the anti-apoptotic
factor Bcl-xL and secretion of IL-2 as well as increased
activation-induced apoptosis in CD4 T cells following anti-
CD3 and CD28 stimulation, all of which would likely lead
to defects in antigen-specific signaling, Th1 responses and
the generation of specific CD4+ T cell effector/memory
subsets.Results
HIV-1 Tg rat CD4+ T cells express reduced levels of CD28
following activation
The abnormally large population of T cells expressing the
naive phenotype and the low number expressing the effector/
memory phenotype in mature rats suggested that the T cells
could be receiving suboptimal antigen stimulation; this led
us to ask whether there was a correlation with defective
activation and/or co-stimulation. We compared expression of
CD28 following anti-CD3 stimulation of CD4+ T cells from
PBMCs of mature (12–15 month old) Tg and control rats
(n = 3) as judged by mean channel fluorescence intensity
(MCF) measured by flow cytometry as described in Mate-
rials and methods. Fig. 1 shows that after stimulation, CD28
MCF of CD4+ T cells from the Tg rats was significantly
decreased (130 ± 20 at 72 h) compared to age-matched con-
trols (390 ± 124, P < 0.05), suggesting that CD28-mediated
co-stimulation of naive CD4+ T cells might be inadequate.
Tg rat CD4+ T cells express reduced levels of IL-2 following
activation
The reduced level of CD28 expressed by Tg rat CD4+ T
cells following anti rat-CD3 stimulation led us to ask whether
this could result in a reduced production of IL-2, a cytokine
whose production requires CD28 signaling. Therefore, we
compared production of IL-2 by purified CD4+ T cells from
mature (12–15 months) Tg and control rats by intracellular
flow cytometry and ELISA following stimulation. CD4+ T
cells from mature rats were analyzed for intracellular IL-2 by
flow cytometry as described in Materials and methods. In a
representative experiment, shown in Figs. 2A and B, sti-
mulation of CD4+ T cells led to an increase in the percentage
of cells expressing IL-2, 11.7% in the non-Tg controls,
compared to 2.3% in the Tg cells. The depicted percentages
(panels A and B) are relative to isotype controls. Fig. 2C
shows averages of the results from multiple experiments. A
mean of 4.5 ± 2.0% Tg rat CD4+ (n = 5) T cells expressed
Fig. 2. Tg rat CD4 T cells express reduced levels of IL-2. Intracellular IL-2 production in peripheral blood T cells from Tg and non-Tg control rats is shown. Purified
CD4+ T cells from 12–15 month old Fisher 344 Tg and non-Tg control rats were analyzed for intracellular IL-2 by flow cytometry following PMA-I stimulation as
described in Materials and methods. Panels A and B show a representative set of data depicting differences in percent cells expressing IL-2 for control and Tg rats,
respectively. Panel C shows the average of data sets for IL-2 intracellular staining with purified CD4+ T cells from multiple (n = 5) Tg and non-Tg control rats as
indicated. Differences between Tg vs. age matched non-Tg controls were statistically significant (P < 0.003). Panel D shows extracellular IL-2 production from anti-
CD3/anti-CD28 activated CD4+ T cells from 12–15 month old Fisher 344 Tg (n = 3) and non-Tg rats (n = 3). Samples were assayed in triplicate by capture ELISA as
described in Materials and methods. Differences were statistically significant (P < 0.04). The numbers represent the mean values ± the standard deviation. * indicates a
significant difference.
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T cells. On average, although there was no significant change
in the MCF from the IL-2 positive Tg CD4 T cells following
stimulation compared to non-stimulated T cells (545 vs. 527,
respectively), there was, however, an approximate 2-fold
increase in MCF from the IL-2 producing CD4 positive T
cells from non-Tg control following stimulation compared to
non-stimulated controls (549 vs. 293, respectively). These
data suggest that IL-2 production in the Tg rat is
quantitatively and possible qualitatively dysregulated. In a
separate set of experiments, CD4+ T cells were stimulated
with plate bound anti-rat CD3 and CD28 as described in
Materials and methods and extracellular production of IL-2
was measured by ELISA. Fig. 2D shows that IL-2 production
from Tg CD4+ T cells (n = 3) was significantly decreased
at 18 h (63 ± 10.4 pg/ml at 5 h and 257.3 ± 67.7 pg/ml at
18 h) relative to that of the age-matched controls (n = 3;
211.6 ± 93.8 pg/ml at 5 h and 821.6 ± 241.7 pg/ml at 18 h;
P < 0.04). The reduction in IL-2 expression combined with
reduced levels of cell surface CD28 suggest that either
decreased levels of CD28 expression by Tg CD4+ T cells
and/or defective CD3 or CD28 signaling contribute to this
phenotype.
Tg rat CD4+ T cells express reduced levels of Bcl-xL following
activation
The reduced level of CD28 expressed by Tg rat CD4+ T
cells following anti rat-CD3 stimulation led us to ask whetherthis was correlated with reduced production of Bcl-xL, an
anti-apoptotic molecule whose expression depends upon CD28-
mediated signal transduction. Therefore, we compared expre-
ssion of Bcl-xL mRNA and protein by real-time quantitative
PCR and by flow cytometry 24 h after stimulation of CD4+
T cells with 10 μg/ml of anti-rat CD3 as described in
Materials and methods. Fig. 3A shows an average of the
results from multiple experiments, which indicate that non-
Tg control cells experienced a significant ∼2.5-fold increase
in Bcl-xL mRNA (P < 0.03). In contrast, cells from age-
matched Tg rats showed a moderate decrease in Bcl-xL
mRNA. Fig. 3B shows that non-Tg CD4+ T cells treated
under the same conditions also showed a significant increase
in Bcl-xL protein, as judged by MCF and determined by
flow cytometry (176 ± 7; P < 0.05) vs. age-matched control
Tg rats (119 ± 11), in agreement with the RNA data. These
differences are consistent with the idea that there is a deficit
in CD28-mediated signal transduction, either because of low
CD28 expression or decreased signaling through the CD28
receptor on Tg rat CD4+ T cells.
HIV-1 Tg rat CD4+ T cells show decreased Lck tyrosine
dephosphorylation following activation
Although CD28 is constitutively expressed on the
majority of T cells, its expression normally increases after
T cell activation (Linsley et al., 1993). Protein tyrosine
phosphorylation and dephosphorylation are essential steps in
the signal transduction cascade leading to T cell activation.
Fig. 3. Tg rat CD4+ T cells express reduced levels of Bcl-xL. PBMCs from
Tg and non-Tg control Fisher 344 rats (n = 3) were stimulated with 10 μg/
ml of anti rat CD3 for 24 h. Panel A shows expression of Bcl-xL mRNA
by CD4+ T cells. CD4+ T cells for were purified by negative selection.
Levels of Bcl-xL mRNA were determined by real-time quantitative PCR as
described in Materials and methods. Samples were analyzed in triplicate
and data were normalized to the expression of 18 s ribosomal mRNA.
Differences were statistically significant (P < 0.03). The numbers represent
the mean values ± the standard deviation. * indicates a significant
difference. Panel B shows expression of Bcl-xL protein by CD4+ T cells.
PBMC were stained for internal Bcl-xL protein and CD4 and mean
channel fluorescence intensities were determined by flow cytometry as
described in Materials and methods. Differences between stimulated non-
Tg and Tg were statistically significant (P < 0.05). The numbers represent
the mean values ± the standard deviation. * indicates a significant
difference.
Fig. 4. Activation-induced Lck Tyrosine dephosphorylation of HIV-1 Tg rat
CD4+ T cells is impaired. Purified CD4+ T (1.0 × 106/ml) cells were pre-
incubated with (10 μg/ml) mouse anti-rat CD3 and CD28 for 30 min at 4 °C,
washed and incubated with 10 μg/ml sheep anti-mouse IgG for 30 min at 4 °C.
Cells were incubated for the indicated times at 37 °C before addition of RIPA
lysis buffer. Proteins in the CD4+ T cell lysate were resolved by SDS-PAGE,
Western blotted and probed with anti-rat phospho-specific Lck p56 (pY505;
upper panel) stripped and probed with total Lck p56 (lower panel) as indicated.
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transduction could be related to the reduced levels of
induction of CD28 on Tg rat CD4+ T cells following anti
CD3 stimulation. Dephosphorylation of Lck at tyrosine
residue 505 (Y505) is one of the early events following
TCR stimulation. Hence, we determined the ability of non-
Tg and Tg CD4+ T cells to dephosphorylate Lck (pY505)
as an indicator of T cell activation. Purified CD4+ T cells
were stimulated at indicated time points with cross-linked
anti rat CD3–CD28 and the dephosphorylation of Lck at
pY505 determined by Western blot analysis as described in
Materials and methods. As indicated by the results from a
representative experiment (Fig. 4), the ratio of pY505/total
Lck following stimulation of the non-Tg control rat CD4+ T
cells was approximately 4-fold decreased compared to that
of Tg CD4+ T cells (0.57, 0.28 and 0.26 following in-
cubation for 0, 0.5 and 1.5 min, respectively compared to
ratios of 0.69, 0.51 and 1.2, respectively). Other Western
blots gave generally similar results (not shown). We interpret
this to mean that there is a deficit in Lck dephosphorylation
that is related to a general dysregulation in TCR/CD28 sig-
naling and may help to explain the decrease in IL-2 and
Bcl-xL expression in activated CD4+ cells from the HIV-1
Tg rats.HIV-1 Tg rats show increased activation-induced apoptosis of
CD4+ lymphocytes following anti-CD3 activation
Failure to induce expression of Bcl-xL, an important anti-
apoptotic molecule in activated T cells, could lead to elevated
levels of activation-induced apoptosis. Apoptosis of CD4+ T
cells in the HIV-1 Tg rat may help explain the abnormal
disruption of Th1 responses and the dysregulated generation of
specific effector/memory subsets. We have previously shown
that mixed T cell populations from Tg rats are susceptible to
induction of apoptosis following activation with PMA-I (Reid
et al., 2004). Here we show that CD4+ T cells from Tg rats are
more susceptible to apoptosis induction following stimulation
than age-matched controls. PBMC were stimulated for 24 h
with 10 μg/ml of plate bound mouse anti-rat CD3 as described
in Materials and methods, and apoptosis was measured by
staining CD3+CD4+ lymphocytes for surface exposure of
Annexin V. Figs. 5A and B show representative Annexin V
staining in stimulated and non-stimulated CD4+ T cells. Fig.
5A shows that 24 h following anti-CD3 stimulation, Annexin
V labeling was 19% and 31% for non-Tg control and Tg rats,
respectively. Fig. 5B shows that during the same time,
Annexin V labeling for the non-stimulated CD4+ T cells was
8.2% and 7% for non-Tg controls and Tg rats, respectively.
Fig. 5C shows that 24 h after stimulation, the mean percent
change in Annexin V labeling in Tg CD4+ T cells was
significantly greater than the controls (n = 6, 26.3 ± 9.9% vs.
14.6 ± 9.8%, P < 0.03). Unexpectedly, when PBMCs were co-
stimulated with anti-CD3 plus anti-CD28 (10 μg/ml anti-CD3
and 1.5 μg/ml anti-CD28), there was an increase in apoptosis
of the Tg CD4+ T cells, although it was not a significant
increase. Apoptosis decreased in the controls, although again
the differences between anti-CD3 alone and anti-CD3 plus
anti-CD28 were also not significant. However, the difference
between costimulated Tg and control CD4+ T cell apoptosis
remained significant (n = 4, 30.0 ± 5.7% vs. 13.0 ± 6.7%,
P < 0.02, respectively; data not shown). The cumulative data
Fig. 5. Increased activation-induced apoptosis of HIV-1 Tg rat CD4+ lymphocytes following anti CD3 activation. Transgenic (n = 6) and age-matched controls (n = 6)
PBMCs were stimulated with plate bound mouse anti-rat CD3 for 24 h at 37 °C. Apoptosis was determined as the difference from stimulated and non-stimulated in
CD3+ CD4+ lymphocytes in the percent of Annexin V labeling as described in Materials and methods. Panels A and B show representative Annexin V staining for
stimulated and non-stimulated populations, respectively. Panel C shows the percent changes in Annexin V labeling. The numbers represent the mean values ± the
standard deviation. * indicates a significant difference (P < 0.03).
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quantitative defect in CD3/CD28 signaling that may contribute
to decreased Bcl-xL production, Lck activation, increased
CD4+ T cell death and abnormal Th1 and memory responses
and the apoptosis of these cells is not rescued by increasing
CD28 signaling.
Discussion
We have previously reported that HIV-1 Tg rats have an
increased susceptibility of CD3+ T cells to apoptosis following
activation with PMA-I and impaired Th1 immunity, as
evidenced by a reduced DTH reaction to antigen in vivo and
IFN-γ production following activation in vitro. Consistent with
the idea that there is a defect in the development of effector/
memory cells, older but not young HIV-1 Tg rats have reduced
numbers of CD4+ and CD8+ cells with an effector/memory
surface phenotype and a reciprocal increase in the numbers of
CD4+ and CD8+ cells with a naive surface phenotype (Reid et
al., 2001, 2004). Here we show that activation of Tg rat CD4+ T
cells with anti CD3 with or without anti CD28 is marked by
reduced Lck (pY505) dephosphorylation, reduced induction of
cell surface CD28, low expression of IL-2 and Bcl-xL, and
increased activation induced apoptosis. These findings were
evident in mature (12–15 months) rats of both Fisher 344 and
Sprague–Dawley strains. It is likely that the inability to
dephosphorylate Lck (pY505) is an early signaling event and
leads to the other differences between Tg rats and age-matched
controls. Inefficient Lck (pY505) dephosphorylation would
preclude proper Lck activation, which in turn would hinder
CD4+ Tcell responses, including T cell antigen receptor (TCR)/CD28 signaling, Th1 cytokine production, effector/memory
development and resistance to activation induced apoptosis.
These outlined immune abnormalities together with the large
population of Tg rat CD4+ T cells expressing the naive
phenotype and the reciprocal paucity of effector/memory
phenotype CD4+ T cells, as previously reported (Reid et al.,
2004), suggest that the reduced sizes in memory phenotype
CD4+ Tcells seen in the Tg rats result from suboptimal priming,
dysregulated T cell expansion and/or differentiation or
increased apoptosis. This idea that the Tg rats show a defect
in T cell activation is supported by data from CD4 T cells of
young Tg rats (with a normal distribution of naive and effector/
memory phenotype T cell subsets) which demonstrate a reduced
ability to proliferate following anti CD3/28 stimulation
compared to age-matched controls (data not shown). Despite
replicating some of the immunopathologies in humans, viral
expression in many existent HIV-1 Tg mouse models is
regulated either by heterologous promoters, which may not
accurately reproduce the patterns of expression driven in natural
infection by the viral promoter, or by viral promoter itself,
which gives the highest expression in the skin (Dickie et al.,
1991), likely because mouse cyclin T does not interact
functionally with Tat (Wei et al., 1998). Although the Tg rat
model that we have developed is also regulated by the viral
promoter, the rat cyclin T appears to be functional (Bieniasz and
Cullen, 2000; Keppler et al., 2001), resulting in efficient viral
transcription in lymph nodes, spleen, thymus and blood (Reid et
al., 2001, 2004). The Tg rats develop defects in Th1 immunity,
their spleens manifest extensive depletion of lymphocytes
within the T cell region and B cell follicular hyperplasia; Tg T
cells are also marked by a skewed early central memory
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apoptosis. Thus, it would be interesting to speculate, based
upon these observations and the recently observed immune
dysfunctions reported here, that during human HIV-1 infection,
HIV-1 accessory and/or structural proteins may induce similar
alterations in immune responses in affected CD4+ T cells,
decreasing antigen-specific primary responses, central memory
(TCM) recall responses and/or the development of functional
effectors before classical characteristics of AIDS develop.
Memory T cells are heterogeneous in terms of their homing
capacity and effector function. This heterogeneity is reflected in
the definition of TCM and effector memory (TEM) T cells
(Lanzavecchia and Sallusto, 2005; Sallusto et al., 2004). TCM
home to lymph nodes, have limited effector function but can
proliferate and become effector cells upon secondary stimula-
tion while, TEM home to peripheral tissues, rapidly produce
effector cytokines but have a limited capacity to proliferate.
During a primary immune response, the strength of TCR and
cytokine stimulation received activate T cells to progressively
acquire tissue homing receptors, effector function and the
capacity to respond to homeostatic cytokines and appear as a
heterogeneous continuum in terms of cell divisions, phenotype
and function (Lanzavecchia and Sallusto, 2005). In CD4+ T
cells, this response declines quickly after antigen withdrawal
and a spectrum of resting memory cell subsets reflects the
subset at the peak of antigenic response(Ahmed and Gray, 1996;
Kaech et al., 2002; Lanzavecchia and Sallusto, 2005; Roman et
al., 2002). During the generation of memory, T cells receiving
weak stimulation are programmed to die because they express
low levels of anti-apoptotic molecules such as Bcl-xL (Gett et
al., 2003; Rathmell and Thompson, 2002). Reports also
demonstrate that, in naive CD4+ T cells, CD28 can specifically
enhance TCR signaling pathways; thus, CD28 signals provide a
key quantitative contribution to potently boost the TCR signal
under low occupancy (Acuto et al., 2003). In our study, it would
be interesting to speculate that the reduced Lck activation in
CD4+ T cells following TCR/CD28 receptor ligation (Fig. 4)
results in qualitative and/or quantitative defects in T cell
activation and CD28 co-stimulation, reduction in IL-2 produc-
tion, Bcl-xL expression and increased susceptibility of Tg
CD4+ T cells to activation-induced apoptosis, culminating in a
dysregulation of memory T cell development, as previously
reported in the HIV-1 Tg rats (Reid et al., 2004).
Which viral proteins are responsible for the observed
abnormalities is of obvious interest. The gag and pol genes
are deleted in the transgene in these rats, but all other viral genes
are present, including the viral regulatory genes. Interestingly,
the HIV-1 protein Nef has been reported to interact with specific
cellular proteins involved in signal transduction (Greenway et
al., 1996, 2003). Of particular interest, Nef has multiple
independent effects on normal T cell function that include
inhibition of signal transduction through the Tcell receptor CD3
complex resulting in the down-regulation of the transcription
factors NF-κB and AP1, inhibition of Lck activation,
modulation of several other effector and signaling pathways
in T cells such as PAK and PKC kinases, activation of NFAT1
and modulation of calcium flux. Nef also down-regulates CD4and CD28 expression, inhibits induction of IL-2 mRNA and
inhibits the expression of Bcl-xL and its anti-apoptotic effect
following T cell activation (Bandres and Ratner, 1994;
Greenway et al., 1996; Lu et al., 1996; Luria et al., 1991;
Manninen et al., 2000; Smith et al., 1996; Tuosto et al., 2003;
Keppler et al., 2005). Reduced CD4+ T cell activation/signaling
could therefore result from Nef binding to Lck and inhibiting
pY505 dephosphorylation/activation. Whether Nef is important
in the HIV-1 Tg rat is not yet clear; however, many of the
immune irregularities correlate with the above activities of the
Nef protein. We are currently investigating this possibility in the
Tg rat.
In summary, we describe CD4 T cell abnormalities in the
HIV-1 Tg rat that include a dysregulation in Lck (pY505)
dephosphorylation, reduced CD28, IL-2 and Bcl-xL expression
and increased activation induced apoptosis. We hypothesize that
the inability to dephosphorylate Lck (pY505) stalls Lck
activation, which in turn hinders CD4+ T cell processes such
as TCR/CD28 signaling, Th1 cytokine production and effector/
memory development, while increasing their susceptibility to
activation induced apoptosis. A subtle decreased cellularity of
the thymic cortex, which has been noted histologically in the
transgenic rats (Huso, unpublished), lends further support to the
notion of altered Lck signaling since dysregulated p56lck
signaling has been shown to affect multiple stages of thymocyte
development and can result in a reduction in double positive
cells in the thymic cortex of rodents(Molina et al., 1992).
Although we do not yet have direct evidence for involvement of
the HIV-1 protein Nef in T cell dysfunctions observed in the
HIV-1 Tg rat, based on the reported functions of this protein, it
is likely that Nef plays a role in the inhibition of key members of
the TCR signaling cascade. Nef may alter the ability of the HIV-
1 Tg rat CD4+ T cells to respond to antigens or cytokines and
contribute to the dysregulated immune responses we describe
here.
Materials and methods
HIV-1 and non-Tg animals
The construction of the HIV-1 transgene and production of
the Tg rats have been described (Reid et al., 2001). Mature (12–
15 months old) specific pathogen-free (SPF) Fisher 344/NHsd
or Sprague–Dawley Tg rats and age-matched non-Tg rats were
used in our analysis. These animals were housed under
pathogen-free conditions in micro-isolator cages on HEPA
filtered ventilated racks. The University of Maryland Biotech-
nology Institute Animal Care and Use Committee approved the
experimental protocol.
Isolation of peripheral blood mononuclear and CD4+ T cells
Isolation of PBMCs has been described (Reid et al., 2004).
CD4+ T cells were isolated by negative selection using the
protocol described by the manufacturer (StemSep, Vancouver,
BC, Canada). Briefly, PBMCs were resuspended at 5.0 × 107
cells/ml and 100 μl of rat CD4 antibody cocktail/ml was added
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was added and incubated for 30 min at 4 °C. CD4+ T cells were
isolated by magnetic separation. Purity of CD4+ T cells was
generally >95%.
Analysis of IL-2, Bcl-xL and CD28 expression by flow
cytometery
Expression of surface and intracellular proteins was assessed
by four-color flow cytometric analysis. PBMCs or CD4 T cells
(1.0 × 106/ml) from Tg and normal controls Fisher 344/NHsd
were analyzed for IL-2 and Bcl-xL production by intracellular
staining. Briefly, for IL-2 staining, purified CD4 T cells were
cultured in RPMI media 1640 supplemented with 10% heat-
inactivated fetal bovine serum (Valley Biomedical, Winchester,
Va.), stimulated for 2 h with 25 ng/ml of phorbol 12-myristrate
13-acetate and 1 μg/ml of ionomycin (PMA-I), treated with
GolgiStop (Beckton Dickerson (BD) Biosciences, San Jose,
CA) and cultured in 5% CO2 at 37 °C for an additional 4 h. For
Bcl-xL staining, PBMCs were stimulated with 10 μg/ml plate
bound purified anti-rat CD3 (G4.18, PharMingen) for 24 h. At
the appropriate time, cells were stained with primary antibody
or an appropriate isotype control according to the manufac-
turer's instructions. Purified CD4 T cells or PBMCs were
stained with FITC anti-rat αβ T cell receptor (R73, PharMin-
gen), and APC anti-rat CD4 (OX-35, PharMingen). Following
surface staining, cells were fixed, permeabilized and stained
with PE anti-rat IL-2 (BL-7015, BioLegend) or PE anti-human
Bcl-xL (7B2.5, SouthernBiotech) according to the manufac-
turer's recommendations. For analysis of CD28 surface
expression, PBMCs were stimulated with 10 μg/ml plate
bound purified anti-rat CD3 (G4.18, PharMingen) for the
indicated time and then stained with FITC anti-rat αβ T cell
receptor (R73, PharMingen), PE anti-rat CD28 (JJ319,
PharMingen) and APC anti-rat CD4 (OX-35, PharMingen).
Samples were acquired using a FACSCalibur (BD Biosciences)
flow cytometer, and the data analyzed by FlowJo software (Tree
Star, Inc., San Carlos, CA.).
Analysis of IL-2 in culture supernatants
Purified CD4+ T cells (1.0 × 106/ml) from Tg and control
Fisher rats were stimulated with 10 μg/ml of plate bound
purified anti-rat CD3 (G4.18, PharMingen) and CD28 (JJ319,
PharMingen), as described above and their supernatants col-
lected at the indicated times. Media were collected and analyzed
in triplicate. IL-2 levels were measured using an ELISA
cytokine detection kit (R&D Systems, Minneapolis, MN)
according to the manufacturer's protocol.
Apoptosis assays
Apoptosis was assayed by surface staining for phosphoti-
dylserine using Annexin V -PE (Pharmingen), and necrotic cells
were stained with 7-AAD (Pharmingen), according to the
manufacturer's instructions. PBMCs from Tg and non-Tg rats
were suspended in RPMI 1640 supplemented with 10% heatinactivated FBS, and plated at 2 × 105 cells/well. The cells were
stimulated with purified plate bound anti-CD3 (10 μg/ml,
G4.18, PharMingen) for 24 h at 37 °C and 5% CO2. Cells were
then stained with FITC-αβ-TCR (R73, PharMingen), PE-
Annexin-V, 7-AAD and APC-CD4 (OX-35) antibodies (Phar-
Mingen). Samples were acquired using FACSCalibur flow
cytometer (BD Biosciences). Analysis was done using FlowJo
software. Data are represented as differences in the percent of
Annexin V binding between stimulated and non-stimulated
CD4+ T cells.
Western blot analysis
Purified rat CD4+ T cells were stimulated as previously
described (Dennehy et al., 2003). Briefly, purified CD4+ T
cells were stimulated with crosslinked (anti-mouse IgG, M
9902, SIGMA), purified mouse anti-rat CD3 (G4.18,
PharMingen) and CD28 (JJ319, PharMingen). Cells were
harvested and lysed, at indicated times, in lysis buffer (5%
Triton X100 in PBS, pH 7.4) with protease inhibitors
(complete with mini-leupeptin, aprotinin and Pefabloc)
(Boehringer-Mannheim). Protein was quantified by BCA
assay (Pierce Biochemicals). Protein was denatured at
70 °C for 10 min in 1× LDS loading buffer (Invitrogen,
Carlsbad CA). Equal amounts of protein were loaded in each
well and electrophoresed on a 4–12% bis-Tris gel (NuPAGE)
(Invitrogen) on the NOVEX X-Cell II system (Invitrogen,
Carlsbad, CA). Transfer to nitrocellulose membranes (Opti-
tran, Schleicher and Schuell, Keene NH) was performed in a
NOVEX transfer system X-Cell II (Invitrogen). Transfer
buffer contained 25 mM bicine, 25 mM bis-Tris, 1.025 mM
EDTA, 0.05 mM chlorbutanol and 15% methanol. Blots were
blocked in PBS-5% non-fat dried milk. Membranes were
probed with primary antibodies to phospho-Lck (pY505,
clone 4, BD Biosciences) and total Lck (3A5, Santa Cruz
Biotechnology). Secondary antibody was conjugated with
horseradish peroxidase (HRP) (Cell Signaling) and detected
with an ECL detection system (Amersham Pharmacia
Biotech, Piscataway, NJ) according to the manufacturer's
protocol.
Real-time PCR for Bcl-xL
To measure the relative amount of defined mRNA,
quantitative real-time PCR analysis was performed using an
ABI GeneAmp 5700 Thermocycler Sequence Detection System
(Applied Biosystems, Foster City, CA). Purified CD4+ T cells
were isolated from control and Tg rats and stimulated at
1.0 × 106 cells/ml for 24 h with 10 μg/ml anti-rat CD3 (G4.18,
PharMingen) and CD28 (JJ319, PharMingen). Total cellular
RNAwas prepared using the Trizol reagent (Invitrogen) and the
volume of each sample was adjusted to 20 μl using DEPC-
treated water. Synthesis of first-strand cDNA (RT reaction) was
performed under standard conditions using 4 μl total cellular
RNA, 2.5 μM random hexamer and 200 units of SuperScript II
RT for 1 h at 42 °C, followed by 5 min at 99 °C. Quantitative
real-time RT-PCR was carried out using QuantiTect SYBR
364 A. Yadav et al. / Virology 353 (2006) 357–365Green PCR kit (Qiagen, Valencia, CA). The rat Bcl-xL gene
was amplified with the following primers: forward 5′-GTAC-
CGGAGAGCATTCAGTG-3′ and reverse 5′-CCTGCATC-
TCCTTGTCTACG-3′. Samples were run in triplicate and
the yield of Bcl-xL PCR product was normalized to the yield
of PCR product generated using an rRNA 18S primer
set (Ambion, Austin, TX). As a DNA contamination con-
trol, equal amounts of RNA were used without reverse
transcriptase.
Statistics
Mean expression for CD28, IL-2 and Bcl-xL was
compared using an independent Student t test. The percent
of apoptotic CD4+ T cells was compared within and between
groups by the Mann–Whitney test for samples exhibiting
non-normal distribution. P values were considered significant
at P < 0.05.
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